Dynamic progression of an intraperitoneal xenograft model of human ovarian cancer and its potential for preclinical trials

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 467-474

  Lin, X J ^a   Chen, X C ^a   Wang, L ^a,c   Wei, Y Q ^b   Kan, B ^b   Wen, Y J ^b   He, X ^a   Zhao, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c PLA 452 Hospital   (China)

Author keywords

Cisplatin; Intraperitoneal disseminated xenograft; Nude mouse; Ovarian neoplasms; Tumor metastasis

Indexed keywords

CA 125 ANTIGEN; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER MODEL; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INOCULATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PANCREAS; PERITONEUM METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; SPLEEN; STAINING; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 38549149793     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jemal A., Tiwari R.C., Murray T., et al.: Cancer statistics, 2004. CA Cancer J. Clin. 54: 9-29, 2004.
2. Ozols R.F.: Progress in ovarian cancer: an overview and perspective. EJC. Supplements 2: 43-55, 2003.
3. Davy M., Mossige J., Johannessen J.V.: Heterologous growth of human ovarian cancer. Acta. Obstet. Gynecol. Scand. 56: 55-59, 1977.
4. Elkas J.C., Baldwin R.L., Pegram M., Tseng Y., Slamon D., Karlan B.Y.: A human ovarian carcinoma murine xenograft model useful for preclinical trials. Gynecol. Oncol. 87: 200-206, 2002.
5. Hamilton T.C., Young R.C., Louie K.G., et al.: Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res. 44: 5286-5290, 1984.
6. Kiguchi K., Kubota T., Aoki D., et al.: A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer. Clin. Exp. Metastasis 16: 751-756, 1998.
7. Massazza G., Tomasoni A., Lucchini A., et al.: Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int. J. Cancer 44: 494-500, 1989.
8. Ward B.G., Wallace K., Shepherd J.H., Balkwill F.: Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res. 47: 2662-2667, 1987.
9. Xu Y., Silver D.F., Yang N.P., et al.: Characterization of human ovarian carcinomas in a SCID mouse model. Gynecol. Oncol. 72: 161-170, 1999.
10. Molpus K.L., Koelliker D., Atkins L., et al.: Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice. Int. J. Cancer 67: 588-595, 1996.
11. Fu X., Hoffman R.M.: Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res. 13: 283-286, 1993.
12. Sood A.K., Seftor E.A., Fletcher M., et al.: Molecular determinants of ovarian cancer plasticity. Am. J. Pathol. 158: 1279-1288, 2001.
13. Xu G.X., Zhong Y., Munir S., Yang B.B., Tsang B.K., Peng C.: Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. J. Clin. Endocrinol. Metab. 89: 5523-5534, 2004.
14. Eagle K., Ledermann J.A.: Tumor markers in ovarian malignancies. Oncologist 2: 324-329, 1997.
15. Liotta L.A., Kohn E.C.: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
16. Matrisian L.M., Cunha G.R., Mohla S.: Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer Res. 61: 3844-3846, 2001.
17. Gregoire M., Lieubeau B.: The role of fibroblasts in tumor behavior. Cancer Metastasis Rev. 14: 339-350, 1995.
18. Iozzo R.V.: Tumor stroma as a regulator of neoplastic behavior. Lab. Investig. 73: 157-160, 1995.
19. Caceres G., Zhu X., Jiao J., Zankina R., Aller A., Andreotti P.: Imaging of luciferase and GFP-transfected human tumors in nude mice. Luminescence. 18: 218-223, 2003.
20. Kanerva A., Zinn K.R., Chaudhuri T.R., et al.: Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol. Ther. 8: 449-458, 2003.